Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $217 | $0 | $0 |
| Research & development | $231,593 | $165,621 | $411,014 | $113,245 |
| Operating expenses | $1.8M | $1.3M | $1.4M | $560,505 |
| Operating income | −$1.8M | −$1.3M | −$1.4M | $560,505 |
| Operating margin | — | −598,243.78% | — | — |
| EBITDA | −$1.3M | −$3.0M | −$1.9M | −$516,030 |
| EBITDA margin | — | −1,373,222.58% | — | — |
| Net income | −$2.2M | −$3.0M | −$2.5M | −$965,150 |
| Net profit margin | — | −1,390,269.12% | — | — |
| Basic EPSper basic share | -$0.01 | -$0.02 | -$0.01 | -$0.00 |
| Diluted EPSper diluted share | -$0.01 | -$0.02 | -$0.01 | -$0.00 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
HAUSMAN MARVIN S MD | 37.76M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 29, 2026Form 4 | HAUSMAN MARVIN S MDTenPercentOwner | Sellcommon stock | 500.0K | $0.02 | $10.0K | 37.76M |
| Apr 20, 2026Form 4 | HAUSMAN MARVIN S MDTenPercentOwner | Sellcommon stock | 1.50M | $0.02 | $30.0K | 38.26M |